Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Pediatric idiopathic multicentric castleman disease is often severe and responds to siltuximab

Bridget Austin, Saishravan Shyamsundar, Mateo Sarmiento Bustamante, Sheila Pierson, Larissa Borys, Kayla McHugh, Abiola Irvine, Kelley Dacus, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Joshua Brandstadter, David Fajgenbaum

Blood (2025) 146 (Supplement 1): 3009.

https://doi.org/10.1182/blood-2025-3009

Published: 2025

Journal Articles

Siltuximab-mediated suppression of CRP is associated with clinical response in idiopathic multicentric castleman disease

Jean-Francois Rossi, Azhaar Ashraf, Yildiz Kelahmetoglu, David Fajgenbaum, Saishravan Shyamsundar, Frits van Rhee

Blood (2025) 146 (Supplement 1): 4788.

https://doi.org/10.1182/blood-2025-4788

Published: 2025

Journal Articles

Identification of Autoantibodies Associated with Connective Tissue Disorders in Idiopathic Multicentric Castleman Disease

Allan Feng, Michael V. Gonzalez, Melanie Mumau, Saishravan Shyamsundar, Paul J. Utz, David C. Fajgenbaum

Blood (2023) 142 (Supplement 1): 1993.

https://doi.org/10.1182/blood-2023-189788

Published: 2023

Journal Articles

Clinical Characteristics and Treatment Outcomes of Idiopathic Multicentric Castleman Disease: Data from a Pediatric Cohort

Saishravan Shyamsundar, Mateo Sarmiento Bustamante, Sheila K. Pierson, Joshua D. Brandstadter, Frits van Rhee, David C. Fajgenbaum

Blood (2023) 142 (Supplement 1): 4415.

https://doi.org/10.1182/blood-2023-183039

Published: 2023